Aribex Acquired by KaVo Dental Group
Aribex, the leader in portable X-ray technology, joins KaVo Group’s impressive portfolio of dental brands.
Orem, Utah – Aribex, a worldwide leader in portable and handheld X-ray products, was recently acquired by the KaVo Group, an affiliation of leading global dental equipment brands, effective immediately. The transaction was completed earlier this week, and integration efforts have commenced.
Aribex, best known for the NOMAD™ handheld and portable X-ray systems, have global market- leading technology that serves clinical, remote and mobile facilities throughout the world. Aribex uniquely serves the dental, veterinary, security and industrial inspection segments. Aribex is based in Orem, Utah and will continue to be the center of excellence for the portable X-ray business. Handheld and portable X-ray systems are the fastest growing segment in intraoral X-ray systems and Aribex’s innovative products are supported by strong patents, intellectual property and a robust new product pipeline.
“We are thrilled to be joining forces with the KaVo Group, a world class dental organization that shares common values and a passion for future success. The KaVo Group combines over 500 years of dental experience with leading global brands and will certainly bolster Aribex’s ability to further accelerate the adoption of handheld X-ray technology,” says Ken Kaufman, President of Aribex.
The KaVo Group consists of market-leading brands such as KaVo, Gendex, DEXIS, i-CAT, Instrumentarium, SOREDEX, Pelton & Crane and Marus. With the acquisition of Aribex, the KaVo Group will reinforce its global imaging footprint and commitment to market-leading innovation.
“We enthusiastically welcome the Aribex team and look forward to further acceleration and expansion of the portable X-ray market,” says Henk van Duijnhoven, Senior Vice President, Dental. “The synergies across our platform are immense from integrated R&D, advances in workflow, technology integration and a passion to advance the quality of care that our health care providers deliver. We also share a passion for serving our dealer partners with excellence.”
Integration efforts between Aribex and the KaVo Group are underway. The group does not anticipate any significant changes that would affect relationships with dealers, suppliers or users.
The transaction is subject to regulatory approval and customary closing conditions, including the absence of a material adverse change with respect to the acquired business. Statements in this document that are not strictly historical, including statements regarding the proposed acquisition, the expected timetable for completing the transaction, future financial and operating results, benefits and synergies of the transaction, future opportunities for the combined company and any other statements about managements’ future expectations, beliefs, goals, plans or prospects that may constitute forward-looking statements. These are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements.